CYP19A1 and early-onset autosomal dominant Alzheimer disease: The increased expression of aromatase is critical in the pathology of such diseases as breast cancer, endometriosis and hypogonadism, while a lack of activity or reduced activity of aromatase may cause reduced functioning of brain neurons and favour the development of such diseases as Alzheimer’s disease or Parkinson’s disease [40].